![](/img/cover-not-exists.png)
The Antianginal Agent, Ranolazine, Reduces Myocardial Infarct Size but Does Not Alter Anatomic No-Reflow or Regional Myocardial Blood Flow in Ischemia/Reperfusion in the Rabbit
Hale, S. L., Kloner, R. A.Volume:
13
Language:
english
Journal:
Journal of Cardiovascular Pharmacology and Therapeutics
DOI:
10.1177/1074248408320278
Date:
May, 2008
File:
PDF, 159 KB
english, 2008